.png){kind=icon}
-
Coordinating Global Capabilities to Support a Gene Therapy Targeting a Rare Neurodegenerative Disorder
Case StudiesJan. 12, 2021
An emerging biotech company and Covance teamed up in early phase efforts to advance a gene therapy that targeted a rare neurodegenerative disease. Learn how multiple teams across Covance collaborated to support the biotech's successful IND with GLP toxicology and biodistribution study and CMC services for the sponsor's unique program.
An emerging biotech company and Covance teamed up in early phase efforts to advance a gene therapy that targeted a rare neurodegenerative disease. Learn how multiple teams across Covance collaborated to support the biotech's successful IND with GLP toxicology and biodistribution study and CMC services for the sponsor's unique program.
